查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物醫藥品CMO·CRO市場:各產品類型，各來源，各服務形式，各國，各地區- 產業分析，市場規模，市場佔有率，2023年～2030年預測
市場調查報告書
商品編碼
1320204

生物醫藥品CMO·CRO市場:各產品類型，各來源，各服務形式，各國，各地區- 產業分析，市場規模，市場佔有率，2023年～2030年預測

Biopharmaceutical CMO And CRO Market with COVID-19 Impact Analysis, By Product Type, Source, By Service Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 241 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年生物製藥CMO/CRO市場規模為324.783億美元，2023年至2030年複合年增長率為5.5%

生物製藥 CMO/CRO 市場 - 市場動態：

生物製藥產業快速成長可望帶動市場需求

2020 年出現顯著成長，主要是由於 COVID-19 大流行的影響。生物製藥行業的知名參與者正在增加投資以提高生產力和效率，促使生物製造商將重點轉向外包活動。如今，生物製藥公司外包資源和資本密集流程，在某些情況下，外包整個生物製造流程。近年來，生物製藥行業經歷了大量的整合，主要是為了擴大業務並保持在生物製藥合約製造和服務市場的競爭力。儘管生物製藥 CMO/CRO 行業本身相對成熟，但新的生物加工工具、創新療法的引入以及生物製藥行業優先事項的變化正在給生物製藥合約製造商帶來額外的壓力。因此，CDMO 正在採用各種業務模式來有效回應客戶和利害關係人的需求。此外，透過將一次性系統納入製造設施，CMO 可以經濟地擴大製造能力。一次性產品可提供快速週轉時間並減少清潔和轉換驗證等相關任務。然而，由於複雜的監管環境和服務，行銷長和客戶之間的合??約談判可能會很困難。對於客戶和 CMO 來說，圍繞智慧財產權、保證和責任、定價和交付時間的問題進一步使這些談判變得複雜。

生物製藥 CMO/CRO 市場 - 主要見解：

  • 根據研究分析師的分析，全球生物製藥 CMO/CRO 市場預計在預測期內（2023-2030 年）每年將以約 5.5% 的複合年增長率成長。
  • 由於生物製藥產業的快速成長，生物製藥CMO/CRO產業預計將出現高成長。
  • 按來源類型劃分，預計哺乳動物將在 2022 年佔最大的市場佔有率
  • 從服務類型來看，合約製造將是 2022 年的主要類型。
  • 按地區劃分，北美將成為 2022 年的主要收入來源。

生物製藥 CMO/CRO 市場 - 區隔分析：

全球生物製藥 CMO/CRO 市場按產品類型、來源、服務類型和地區區隔。

依來源類型，市場分為哺乳動物和非哺乳動物。2022年，哺乳動物區隔市場佔有較大市場。這主要是由於產業內部專業知識有限，促使公司依賴哺乳動物系統，這些系統能夠將類似人類的翻譯後修飾引入複雜的蛋白質療法中。除其他福利外，該區隔市場還受益於先進表達系統、改進的過程監控解決方案、細胞系工程工具、自動篩選方法和一次性設備的引入，進一步推動了其增長和成功。

市場依服務類型分為兩類：合約製造與合約研究。2022年，合約製造業佔最大的市場佔有率。另一方面，合約研究領域預計在預測期內複合年增長率最快。這種成長的關鍵推動因素是生物製藥公司外包其研究活動的趨勢不斷增加。業內有許多合約製造組織 (CMO) 和機會主義 CMO，為生物製藥公司提供廣泛的服務。這些服務涵蓋端到端，從細胞培養到填充和精加工服務。此外，客戶正在積極投資於外包其產品開發計劃的製造方面。對外包的日益關注促進了研究合約領域的快速成長。

生物製藥 CMO/CRO 市場 - 地理洞察：

從地理來看，該市場遍佈北美、拉丁美洲、歐洲、亞太地區和中東非洲。這些地區根據其開展業務的國家進一步劃分。

生物製藥 CMO/CRO 市場 - 競爭格局：

生物製藥CMO/CRO市場由大量現有中型、中小型CMO/CRO組成，呈現碎片化結構。這些市場進入者中有許多是私人控股公司或私募股權公司投資組合的一部分。為了提高專案吞吐量和產品質量，CMO 工廠擴大採用自動化和創新技術。因此，大分子製造商越來越有興趣與 CMO 合作，以滿足對生物製劑不斷增長的需求。

最近動態

2023年3月，韓美製藥將參加2023年BIO-Europe春季會議，並以CMO（合約藥物製造組織）和CDMO（合約藥物開發和製造組織）的身份正式啟動業務活動。

研究的主要特點

  • 本研究報告提供了生物製藥 CMO/CRO 市場的市場規模、複合年增長率 (CAGR%) 以及以 2022 年為基準年的估計和預測（2023-2030 年）。
  • 這份研究報告讓客戶深入了解生物製藥 CMO/CRO 市場的最新趨勢。
  • 該研究報告闡明了各個區隔市場/國家的潛在成長機會，並解釋了生物製藥 CMO 和 CRO 市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、現有公司面臨的挑戰以及維持生物製藥 CMO/CRO 市場的成長因素。
  • 研究範圍內詳細討論了 COVID-19 對生物製藥 CMO/CRO 市場規模、預測、複合年增長率和市場動態的影響。本報告也詳細介紹了新冠疫情後生物製藥 CMO/CRO 市場。
  • 為了向本報告的使用者提供生物製藥 CMO 和 CRO 市場的全面了解，本報告也對生物製藥 CMO 和 CRO 市場的競爭格局和關鍵創新者進行了分析。
  • 該研究涵蓋了根據市場規模、成長率和吸引力對所有行業領域進行基準測試的成長前景映射分析。
  • 主要市場參與者的詳細公司簡介可協助您了解在生物製藥 CMO/CRO 市場中營運的公司的財務資訊和策略性舉措。
  • 此外，該報告還揭示了全球和區域市場主要參與者的重要收購和併購、聯盟和合資企業、新品發布、研發和區域擴張。Masu。
  • 全球生物製藥 CMO/CRO 市場報告主要針對該產業的各個利害關係人，例如供應商、投資者、新進業者、經銷商和財務分析師。

目錄

第1章 生物醫藥品CMO·CRO市場概要

  • 調查範圍
  • 市場估計年數

第2章 摘要整理

  • 市場明細
  • 競爭考察

第3章 生物醫藥品CMO·CRO的主要市場趨勢

  • 生物醫藥品CMO·CRO推動市場要素
  • 生物醫藥品CMO·CRO阻礙市場要素
  • 生物醫藥品CMO·CRO市場機會
  • 生物醫藥品CMO·CRO市場未來趨勢

第4章 生物醫藥品CMO·CRO產業的調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法規結構的分析

第5章 生物醫藥品CMO·CRO市場:COVID-19影響分析

  • 新型冠狀病毒感染疾病前的影響分析
  • 新型冠狀病毒感染疾病後的影響分析

第6章 生物醫藥品CMO·CRO市場形勢

  • 生物醫藥品CMO·CRO市場佔有率分析，2022年
  • 各主要製造商的明細資料
    • 確立的企業的分析
    • 新興企業的分析

第7章 生物醫藥品CMO·CRO市場-各產品類型

  • 概要
    • 各產品類型市場區隔佔有率分析
    • 生技藥品
    • 生物相似藥

第8章 生物醫藥品CMO·CRO市場- 各來源

  • 概要
    • 各來源市場區隔佔有率分析
    • 哺乳類
    • 非哺乳類

第9章 生物醫藥品CMO·CRO市場- 各服務形式

  • 概要
    • 各服務形式市場區隔佔有率分析
    • 受託製造
    • 受託調查

第10章 生物醫藥品CMO·CRO市場-各地區

  • 簡介
  • 北美
    • 概要
    • 北美的生物醫藥品CMO·CRO的主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概要
    • 歐洲的生物醫藥品CMO·CRO的主要製造商
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區(APAC)
    • 概要
    • 亞太地區的生物醫藥品CMO·CRO的主要製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 概要
    • 南美的生物醫藥品CMO·CRO的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概要
    • 中東及非洲的生物醫藥品CMO·CRO的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析- 生物醫藥品CMO·CRO產業

  • 競爭儀表板
  • 企業簡介
    • Boehringer Ingelheim GmbH
    • Lonza Group AG
    • Inno Biologics Sdn Bhd
    • Rentschler Biopharma SE
    • JRS Pharma
    • Biomeva GmbH
    • ProBioGen AG
    • Fujifilm Diosynth Biotechnologies USA, Inc.
    • Toyobo Co., Ltd.
    • Samsung Biologics
    • Thermo Fisher Scientific Inc(Patheon &PPD)
    • CMC Biologics
    • WuXi Biologics
    • AbbVie Inc.
    • Binex Co., Ltd.
    • Charles River Laboratories International, Inc.
    • ICON Plc

第12章 分析師的全方位展望

Product Code: ANV1515

REPORT HIGHLIGHT

Biopharmaceutical CMO And CRO Market size was valued at USD 32,478.3 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.

Biopharmaceutical CMO (Contract Manufacturing Organization) and CRO (Contract Research Organization) are specialized service providers within the biopharmaceutical industry that offer outsourcing solutions to biopharmaceutical companies. These CMOs have specialized facilities and expertise to manufacture a wide range of biopharmaceuticals, including biologics, vaccines, gene therapies, and other complex biological products. Biopharmaceutical CMOs play a crucial role in the production of these advanced therapeutics, as they often require sophisticated and specialized manufacturing processes. CROs on the other hand provide research and development support, conducting various phases of preclinical and clinical trials, as well as other research activities. Biopharmaceutical CROs play a critical role in advancing the drug development process by providing expertise, resources, and infrastructure for conducting clinical trials and other research studies

Biopharmaceutical CMO And CRO Market- Market Dynamics:

Rapid growth of biopharmaceutical industry is expected to propel the market demand

The year 2020 witnessed remarkable growth, primarily attributed to the impact of the COVID-19 pandemic. Prominent participants in the biopharmaceutical industry increased their investments to improve productivity and efficiency, leading bio manufacturers to shift their focus towards outsourcing activities. Currently, biopharma companies are outsourcing resource and capital-intensive steps, and in some instances, the entire biomanufacturing process, thus driving the demand for contract-based services. In recent years, the biopharmaceutical industry has experienced a significant number of consolidations, primarily driven by the aim of expanding businesses and maintaining competitiveness in the biopharmaceutical contract manufacturing and services market. While the biopharmaceutical CMO & CRO industry itself is relatively mature, the introduction of new bioprocessing tools, innovative therapeutics, and shifting priorities in the bio/pharmaceutical industry have placed additional pressure on contract biomanufacturers. Consequently, CDMOs are adopting various business models to effectively address the needs of their clients and stakeholders. Moreover, the incorporation of single-use systems in production facilities allows CMOs to economically expand their manufacturing capacity. Single-use products offer rapid turnaround times and reduce associated tasks such as cleaning and changeover validation. However, contract negotiations between CMOs and customers can be challenging due to the complexities of the regulatory landscape and services involved. Issues related to intellectual property rights, warranties & liabilities, pricing, and timelines add further complexity to these negotiations for both clients and CMOs.

Biopharmaceutical CMO And CRO Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Biopharmaceutical CMO And CRO market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)
  • The Biopharmaceutical CMO And CRO industry is projected to grow at due to rapid growth of biopharmaceutical industry
  • Based on source type, mammalian was predicted to show maximum market share in the year 2022
  • Based on service type, Contract Manufacturing was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Biopharmaceutical CMO And CRO Market- Segmentation Analysis:

The Global Biopharmaceutical CMO And CRO Market is segmented on the basis of Product Type, By Source, By Service Type, and Region.

The market is divided into two categories based on Source Type: mammalian and non- mammalian. In 2022, the mammalian segment dominated the market with a significant market share. This is mainly due to the industry's limited internal expertise, driving companies to rely on mammalian systems for their ability to introduce human-like post-translational modifications to complex protein therapeutics. Additionally, the segment has greatly benefited from the introduction of advanced expression systems, improved process monitoring solutions, cell line engineering tools, automated screening methods, and disposable devices, further bolstering its growth and success.

The market is divided into two categories based on Service type: Contract Manufacturing and Contract research. In 2022, the Contract Manufacturing segment accounted for the largest market share. On the other hand, the Contract Research segment is projected to experience the fastest CAGR during the forecast period. This growth is primarily driven by the increasing trend of biopharmaceutical companies outsourcing their research activities. Within the industry, there is a significant number of Contract Manufacturing Organizations (CMOs) and opportunistic CMOs that offer a wide array of services to biopharmaceutical entities. These services range from end-to-end coverage, starting from cell cultivation to fill/finish services. Additionally, clients are heavily investing in outsourcing the manufacturing aspect of their product development programs. This increased focus on outsourcing is contributing to the rapid growth of the Contract Research segment.

Biopharmaceutical CMO And CRO Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Biopharmaceutical CMO And CRO Market- Competitive Landscape:

The market exhibits a fragmented structure as it comprises a significant number of established and medium-to-small-sized CMOs and CROs. Many of these market participants are privately held or fall under the portfolios of private equity firms. In order to enhance project throughput and product quality, CMOs are increasingly adopting automation and innovative technologies at their facilities. As a result, large molecule manufacturers are becoming more interested in collaborating with CMOs to meet the rising demand for biologics.

Recent Developments:

In March 2023, Hanmi Pharmaceutical has announced its intention to take part in the 2023 BIO-Europe Spring Conference, where it will formally launch its CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) business activities.

Key features of the study:

  • This proposed research study on Biopharmaceutical CMO And CRO market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Biopharmaceutical CMO And CRO market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biopharmaceutical CMO And CRO market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biopharmaceutical CMO And CRO market
  • Impact of COVID-19 on Biopharmaceutical CMO And CRO market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biopharmaceutical CMO And CRO market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Biopharmaceutical CMO And CRO market, we have also included competitive landscape and key innovator analysis for the Biopharmaceutical CMO And CRO market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biopharmaceutical CMO And CRO market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Biopharmaceutical CMO And CRO market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET KEY PLAYERS

  • Boehringer Ingelheim GmbH
  • Lonza Group AG
  • Inno Biologics Sdn Bhd
  • Rentschler Biopharma SE
  • JRS Pharma
  • Biomeva GmbH
  • ProBioGen AG
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Toyobo Co., Ltd.
  • Samsung Biologics
  • Thermo Fisher Scientific Inc (Patheon & PPD)
  • CMC Biologics
  • WuXi Biologics
  • AbbVie Inc.
  • Binex Co., Ltd.
  • Charles River Laboratories International, Inc.
  • ICON Plc

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY PRODUCT TYPE

  • Biologics
  • Biosimilars

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SOURCE

  • Mammalian
  • Non-mammalian

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY SERVICE TYPE

  • Contract Manufacturing
  • Contract Research

GLOBAL BIOPHARMACEUTICAL CMO AND CRO MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biopharmaceutical CMO And CRO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biopharmaceutical CMO And CRO Market Snippet by Product type
    • 2.1.2. Biopharmaceutical CMO And CRO Market Snippet by Source
    • 2.1.3. Biopharmaceutical CMO And CRO Market Snippet by Service Type
    • 2.1.4. Biopharmaceutical CMO And CRO Market Snippet by Country
    • 2.1.5. Biopharmaceutical CMO And CRO Market Snippet by Region
  • 2.2. Competitive Insights

3. Biopharmaceutical CMO And CRO Key Market Trends

  • 3.1. Biopharmaceutical CMO And CRO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biopharmaceutical CMO And CRO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biopharmaceutical CMO And CRO Market Opportunities
  • 3.4. Biopharmaceutical CMO And CRO Market Future Trends

4. Biopharmaceutical CMO And CRO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biopharmaceutical CMO And CRO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biopharmaceutical CMO And CRO Market Landscape

  • 6.1. Biopharmaceutical CMO And CRO Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biopharmaceutical CMO And CRO Market - By Product type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product type, 2022 & 2030 (%)
    • 7.1.2. Biologics
    • 7.1.3. Biosimilars

8. Biopharmaceutical CMO And CRO Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
    • 8.1.2. Mammalian
    • 8.1.3. Non-mammalian

9. Biopharmaceutical CMO And CRO Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2022 & 2030 (%)
    • 9.1.2. Contract Manufacturing
    • 9.1.3. Contract Research

10. Biopharmaceutical CMO And CRO Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biopharmaceutical CMO And CRO Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biopharmaceutical CMO And CRO Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biopharmaceutical CMO And CRO Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Biopharmaceutical CMO And CRO Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Biopharmaceutical CMO And CRO Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Service Type, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Biopharmaceutical CMO And CRO Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Boehringer Ingelheim GmbH
    • 11.2.2. Lonza Group AG
    • 11.2.3. Inno Biologics Sdn Bhd
    • 11.2.4. Rentschler Biopharma SE
    • 11.2.5. JRS Pharma
    • 11.2.6. Biomeva GmbH
    • 11.2.7. ProBioGen AG
    • 11.2.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
    • 11.2.9. Toyobo Co., Ltd.
    • 11.2.10. Samsung Biologics
    • 11.2.11. Thermo Fisher Scientific Inc (Patheon & PPD)
    • 11.2.12. CMC Biologics
    • 11.2.13. WuXi Biologics
    • 11.2.14. AbbVie Inc.
    • 11.2.15. Binex Co., Ltd.
    • 11.2.16. Charles River Laboratories International, Inc.
    • 11.2.17. ICON Plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biopharmaceutical CMO And CRO Market: Product type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product type
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Product type 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Source 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Service Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Service Type 2018-2030 (USD Million)
  • TABLE Biopharmaceutical CMO And CRO Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biopharmaceutical CMO And CRO Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE North America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Europe Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Latin America Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Product type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biopharmaceutical CMO And CRO Market, by Service Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Biopharmaceutical CMO And CRO Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product type segment market share analysis, 2022 & 2030
  • FIGURE Product type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Source segment market share analysis, 2022 & 2030
  • FIGURE Source segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Service Type segment market share analysis, 2022 & 2030
  • FIGURE Service Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Europe Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Germany Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE India Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Brazil Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Biopharmaceutical CMO And CRO Market share analysis by country, 2022
  • FIGURE Saudi Arabia Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Biopharmaceutical CMO And CRO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)